OOCYTE AND EMBRYO DONATION - EVALUATION OF 412 CONSECUTIVE TRIALS

被引:50
作者
PADOS, G [1 ]
CAMUS, M [1 ]
VANWAESBERGHE, L [1 ]
LIEBAERS, I [1 ]
VANSTEIRTEGHEM, A [1 ]
DEVROEY, P [1 ]
机构
[1] VRIJE UNIV HOSP BRUSSEL,CTR REPROD MED,LAARBEEKLAAN 101,B-1090 BRUSSELS,BELGIUM
关键词
EMBRYONIC IMPLANTATION; HORMONE REPLACEMENT THERAPY; OOCYTE DONATION;
D O I
10.1093/oxfordjournals.humrep.a137803
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A total of 199 patients (412 consecutive cycles) were treated by oocyte-embryo donation in 336 replacement cycles. Of these, 2% involved intra-uterine embryo transfers, 38 zygote intra-Fallopian transfers (ZIFT) and two gamete intra-Fallopian transfers (GIFT). Of the 336 replacements, 244 (73%) constituted transfers of fresh concepti and 92 (27%) of frozen-thawed ones. A total of 85 pregnancies were achieved of which 16 ended in preclinical abortions, giving a clinical pregnancy rate of 34.7% per patient, 20.5% per transfer and a take-home baby rate of 29.1% per patient. The pregnancy rate was significantly higher (P < 0.05) following fresh gamete or embryo replacement (23%; 56/244) than following that of frozen-thawed embryos (14.1 %; 13/92). No significant difference was observed when intra-Fallopian replacement was applied (27.5%; 11/40) as opposed to intrauterine (19.6%; 58/2%). Ovarian function was not found to be of significant importance to the achievement of pregnancies after oocyte donation since comparable pregnancy rates per replacement and per started cycle were obtained in patients with ovarian failure and in those with functional ovaries (19% and 15.4%; 24.2% and 20.2% respectively). Comparison of the implantation and abortion rates between these two groups did not reveal any significant difference (11.1% and 11.1% versus 14.8% and 16.6%). The highest pregnancy rate among patients with ovarian failure was observed in those with primary ovarian failure (26.4%; 14/53), while the lowest was among women who had received chemotherapy and/or radiotherapy (9%; 1/11). Of patients with functional ovaries, those with genetic indications had the highest pregnancy rate (30.8%; 12/39).
引用
收藏
页码:1111 / 1117
页数:7
相关论文
共 44 条
[1]  
Abdalla H., Leonard T., Cryopreserved zygote intrafallopian transfer for anonymous oocyte donation, Lancet, 1, pp. 835-839, (1988)
[2]  
Abdalla H., Baber R., Kirkland A., Leonard T., Power M., Studd J., A report on 100 cycles of oocyte donation
[3]  
factors affecting the outcome, Hum. Reprod, 5, pp. 1018-1022, (1990)
[4]  
Asch R., Balmaceda J., Ord T., Borrero C., Cefalu E., Gastaldi C., Rojas F., Oocyte donation and gamete intrafallopian transfer in premature ovarian failure, Fertil. Steril, 49, pp. 263-267, (1988)
[5]  
Balmaceda J., Alam V., Roszijtein D., Ord T., Snell K., Asch R., Embryo implantation rates in oocyte donation: A prospective comparison of tubal versus uterine transfers, Fertil. Steril, 57, pp. 362-365, (1992)
[6]  
Borrero C., Remohi J., Ord T., Balmaceda J., Rojas F., Asch R., A program of oocyte donation and gamete intra-Fallopian transfer, Hum. Reprod, 4, pp. 275-279, (1989)
[7]  
Bourgain C., Devroey P., Waesberghe L., Smitz J., Steirteghem A.C., Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure, Hum. Reprod, 5, pp. 537-543, (1990)
[8]  
Buvat-Herbaut M., Buvat J., Marcolin G., Guittard J., Herbaut J., Louvet A., Couplet G., Results of a one year oocyte donation programme using exclusively so called “excess" oocytes from IVF patients, Presented at the 7Th World Congress on IVF and Assisted Procreation, P8, (1991)
[9]  
Chan C., Cameron J., Findlay J., Healy D., Leeton F., Lutjen P., Rogers P., Trounson A., Wood E., Oocyte donation and in vitro fertilization for hypergonadotropic hypogonadism: Clinical state of the art, Obstet. Gynecol. Surv, 42, pp. 350-356, (1987)
[10]  
Cornet D., Alvarez S., Antoine J., Tibi C.H., Mandelbaum J., Plachot M., Salat-Baroux J., Pregnancies following ovum donation in gonadal dysgenesis, Hum. Reprod, 5, pp. 291-293, (1990)